THIS WEBSITE IS ON SALE!!
This repository of information on pharma regulatory affairs in Latin America could be yours. GET THE READER FLOW YOU NEED TO PROMOTE YOUR PHARMA CONSULTING BUSINESS!! 1,500 VISITORS A MONTH AND GROWING. GET IN TOUCH! inesitag@hotmail.com / maria@latampharmara.com-
Our friends:
Index
- Regulatory Affairs in Emerging Markets
- Fundamentals of Regulatory Affairs
- Argentina
- Colombia
- Mexico
- Central America
- Interesting
- Blog
- Get in touch!
Tag Archives: drug adverse reactions
Brazil: ANVISA bans Lorcaserin (Belviq)
Today ANVISA, the Brazilian health authority with competence on the control of pharmaceutical products and APIs, banned the manufacturing, import, commercialization, manipulation and use of the API Lorcaserin. Lorcaserin is the drug substance of Belviq, an innovative weight-loss product that … Continue reading
ANMAT launches online platform to report drug adverse reactions
On July 10th, 2013, ANMAT implemented a system for electronic submission of reports on adverse reactions to drug products. The system consists on an online form accessible from the website of the National System of Pharmacovigilance. You can access the online … Continue reading